Emergence Therapeutics Licenses Synaffix ADC Technology Platform in $360M Deal
/PRNewswire/ -- Synaffix B.V. (Synaffix) and Emergence Therapeutics AG ("Emergence") ("the Companies") today announce that the Companies have entered into a...
Stay updated with breaking news from Platform Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Synaffix B.V. (Synaffix) and Emergence Therapeutics AG ("Emergence") ("the Companies") today announce that the Companies have entered into a...
The judges for the 2022 Schroders UK Platform Awards have now discussed the entries and decided upon the shortlists from which the winner will be chosen.
/PRNewswire/ -- The health and wellness industry is massive. While there are many facets of the movement, using natural products is high on the list of...
/PRNewswire/ -- Western medicine tends to be associated with scientific precision and a detailed rigor that is unparalleled. In comparison, Eastern medicine is...
Gamida Cell has a key FDA approval pending which could shift the trajectory of the company and the stock. Click here for a full investment analysis.